Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Here’s why AstraZeneca shares are a great buy for me

| Manika Premsingh

AstraZeneca is a low-risk stock, but it has also given strong returns over time.

Read more »

Investing Articles

Pharma stock investing: Biogen vs AstraZeneca

| Kirsteen Mackay

Biogen has had its breakthrough Alzheimer's drug approved and AstraZeneca has several exciting drugs in development. Are these pharma stocks…

Read more »

Investing Articles

1 FTSE 100 and 1 FTSE 250 stock to buy

| Rupert Hargreaves

This Fool highlights one FTSE 100 and one FTSE 250 stock that he would buy for his portfolio for large…

Read more »

Investing Articles

ESG investing: should I buy these 2 UK shares?

| Christopher Ruane

As ESG investing grows, Christopher Ruane digs into the pros and cons of adding two UK shares with environmental and…

Read more »

Investing Articles

The AstraZeneca share price is climbing. Is growth really here again?

| Alan Oscroft

The AstraZeneca share price has been volatile in recent years, though we've seen a strong run since March. Will I…

Read more »

Investing Articles

4 FTSE 100 shares I’d buy in June

| Kirsteen Mackay

I've got my eye on four FTSE 100 stocks to buy and hold for five to 10 years. These are…

Read more »

Investing Articles

GlaxoSmithKline shares: why I’m not buying

| Dan Peeke

GlaxoSmithKline has been popular with investors for decades. Despite this, Dan Peeke is wary of investing in the pharmaceutical giant.

Read more »

Investing Articles

AstraZeneca stock: time to sell?

| Pam Narang

Looking beyond the company’s vaccine woes, is now the time to make the most of the uptick in AstraZeneca stock…

Read more »

Investing Articles

The AstraZeneca share price is rising fast. Here’s what I’d do now

| Manika Premsingh

The AstraZeneca share price is rising fast after its robust results. But can it rise much further from its already…

Read more »

Investing Articles

ESG investing: which UK companies might I invest in?

| Andy Ross

A look at ESG investing and two UK FTSE 100 companies with strong ESG credentials, which might make them appealing…

Read more »

Investing Articles

Novacyt or AstraZeneca: which biotech stock should I buy?

| Kirsteen Mackay

Novacyt and AstraZeneca are two biotech stocks working in the realms of fighting the Covid-19 pandemic. Are either good long-term…

Read more »

Scientist filling a needle
Investing Articles

3 reasons to buy the FTSE 100’s AstraZeneca stock now

| Kevin Godbold

Here's why I'd be keen to get a solid-looking business such as AstraZeneca into my long-term diversified portfolio right now.

Read more »